RAPP Rapport Therapeutics22.59-5.44 (-19.4%)
RAPP Rapport Therapeutics27.89-3.58 (-11.4%)
After Hours Decliner
RAPP Rapport Therapeutics31.47+17.11+119.2%
After Hours:31.00-0.47 (-1.5%)
Rapport Announces Proposed Public Offering of Common Stock
Globe NewswireMon, 8-Sep 4:05 PM
RAPP Rapport Therapeutics34.48+20.12 (+140.1%)